Inspire Medical Systems Analysts Lower Their Forecasts After Q2 Results

Inspire Medical Systems, Inc. (NYSE:INSP) reported second-quarter results and cut its FY25 guidance below estimates on Monday.

Inspire Medical Systems reported quarterly earnings of 45 cents per share which beat the analyst consensus estimate of 21 cents per share. The company reported quarterly sales of $217.086 million which beat the analyst consensus estimate of $214.480 million.

Inspire Medical Systems lowered its FY2025 GAAP EPS guidance from $2.20-$2.30 to $0.40-$0.50 and also lowered sales guidance from $940.000 million-$955.000 million to $900.000 million-$910.000 million.

“The full launch of our FDA-cleared Inspire V system in the U.S. is an important milestone for Inspire. We have been receiving strong positive feedback from both surgeons and patients who value the simplified procedure and excellent patient outcomes enabled by this next generation technology,” said Tim Herbert, Chairman and CEO of Inspire. ...